| Y |
| Yaari O |
- |
Autologous Bone and Marrow Grafted within a Clot of Platelet Rich Plasma Construct Normal Viable Bone |
| Yagi H |
- |
Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo |
| Yakovlev S |
- |
Molecular Mechanisms of Thrombin-Mediated Fibrin Assembly |
| Yallop D |
- |
Clinical and Laboratory Diagnosis of Heparin Induced Thrombocytopenia (HIT) |
| Yamada S |
- |
Endocannabinoid Anandamide Induces High Mobility Group Box 1 (HMGB1) Protein Release in Monocytes and Macrophages |
| |
- |
High Mobility Group Box Protein Is Increased in the Plasma and May Have a Role in Development of Organ Failure in DIC |
| |
- |
Thrombomodulin Binds Lethal Cytokine HMGB1 and Neutralizes Its Pro-inflammatory Activity: Novel Cytoprotective Action of Thrombomodulin |
| Yamakawa M |
- |
Cardiac Involvement in Pathologic Findings of Factor XIII Knockout Mice |
| Yamaki T |
- |
The Japanese Vein Study: The 2nd Survey of Deep Vein Thrombosis |
| Yamamoto N |
- |
Negative Regulation of Platelet Function by a Secreted Cell Repulsive Protein, Semaphorin 3A |
| Yamamoto J |
- |
Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice |
| Yamamoto R |
- |
Inhibition of 5-Hydroxytriptamine2A (5-HT2A) Receptor Prevents Occlusive Thrombus Formation on Neointima of Rabbit Femoral Artery |
| Yamamoto K |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
| |
- |
In vitro Characterization of Two Missense Mutations Associated with Quantitative Protein S Deficiency |
| Yamamoto H |
- |
Domain A1 in Unfolded von Willebrand Factor Can Recruit Flowing Platelets to Collagen Surfaces Independently of Domain A3 |
| Yamanaka T |
- |
Plasminogen Activator Releasing Activity in Coffee |
| Yamashita A |
- |
Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo |
| |
- |
Six years' Experience of Regular Continuous Prophylactic Infusion of Clotting Factor Concentrates in Infants and Young Children with Severe Hemophilia A and B in Japan |
| |
- |
Inhibition of 5-Hydroxytriptamine2A (5-HT2A) Receptor Prevents Occlusive Thrombus Formation on Neointima of Rabbit Femoral Artery |
| |
- |
Retrospective Study on Thrombosis in Japanese Children |
| Yamashita A |
- |
Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction |
| Yamazaki M |
- |
Roles of Adhesion Molecules in the Development of Antiphospholipid Syndrome: Key Roles of E-selectin in the Induction of Antiphospholipid Antibodies |
| Yamazaki Y |
- |
Molecular Cloning of Novel Vascular Endothelial Growth Factors from Snake Venoms |
| Yamazaki K |
- |
HMG-CoA Reductase Inhibitors Reduce the Synthesis of Tissue Factor and Factor VII and Increase the Synthesis of Tissue Factor Pathway Inhibitor in Human Mononuclear Cells |
| Yamazaki M |
- |
HMG-CoA Reductase Inhibitors Reduce the Synthesis of Tissue Factor and Factor VII and Increase the Synthesis of Tissue Factor Pathway Inhibitor in Human Mononuclear Cells |
| Yamazaki T |
- |
In vitro Characterization of Two Missense Mutations Associated with Quantitative Protein S Deficiency |
| Yamazaki Y |
- |
C-terminal Heparin-Binding Peptide of Snake Venom VEGF Specifically Blocks VEGF-stimulated Endothelial Cell Proliferation |
| Yamazaki T |
- |
In vitro Characterization of Increased Factor V 1 Form by Factor V R2 Haplotype |
| Yamazaki Y |
- |
Identification of Heparin-Binding Region of Snake Venom VEGF (VEGF-F) and Its Blocking Effect on VEGF-A165 |
| Yamazaki K |
- |
Functional Analysis o Two Recombinant Missense Mutant Factor XI, F221S ad C212R |
| Yamazaki M |
- |
Functional Analysis o Two Recombinant Missense Mutant Factor XI, F221S ad C212R |
| Yan LX |
- |
Platelet Antibody Analysis in Patients with Platelet Transfusion Refractoriness |
| Yan LX |
- |
In vitro Expression Study on the Antithrombin Gene C2759T (Leu99Phe) Mutation |
| Yanagi M |
- |
Induction of Renal PAI-1 Gene Expression in a Rat Model of Type-2 Diabetic Nephropathy and Role of Albumin in PAI-1 Induction |
| Yañez L |
- |
Hemostatic Abnormalities in Oncolgic Patients |
| Yánez L |
- |
Vein Trombosis in Pediatric Patients |
| Yang H |
- |
Platelet Aggregation Independent of Von Willebrand Factor and Fibrinogen |
| Yang M |
- |
The Effect of Chinese Danggui and PDGF on Thrombopoiesis in Irradiated Mice |
| |
- |
Neuro-microenvironment and Neurotrophic Factors Support ex vivo Expansion of Megakaryocytic Progenitor Cells |
| Yang L |
- |
The Functional Significance of the Autolysis Loop of Protein C and Activated Protein C |
| |
- |
Mutagenesis Studies toward Understanding the Mechanism of Cofactor Function of Thrombomodulin in Promoting Protein C Activation by Thrombin |
| Yang M |
- |
The Role of Serotonin and Melatonin on Hematopoiesis and Platelet Production |
| Yang X |
- |
Probable Involvement of Endogenous Platelet Protease(s) in PAR-Dependent Platelet Activation |
| Yang C |
- |
Crystal Structure of CIB1, an Endogenous Inhibitor of Platelet Integrin aIIbb3 Activation: Delineation of a New Family of Calcium-Binding Proteins |
| Yantorno S |
- |
Impact of Different Thromboplastins on the International Normalized Ratio and MELD Score in Patients with Cirrhosis Listed for Liver Transplantation |
| Yap CL |
- |
Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury |
| |
- |
Thrombospondin as a Regulator of von Willebrand Factor Multimer Size |
| Yardimci KT |
- |
The Effects of Clopidogrel and Nadroparine on Elevated Thrombolytic Risk and Apoptotic Process in Hypercholesterolemia |
| |
- |
The Role of Gamma-Glutamyltransferase Activity on Early Platelet Apoptotic Process |
| Yarnell J |
- |
Which Haemostatic Variables Add to the Prediction of Cardiovascular Events by Conventional Risk Factors? The Caerphilly Study |
| Yarnold PR |
- |
Evolving Risk for Thromboembolism in Spinal Cord Injury |
| Yaron G |
- |
CRP Induces Platelet-Endothelial Adhesion Under Flow |
| Yashiki A |
- |
Regulation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Gene Expression in Growth-Promoted Hepatocytes and Role of TAFI in Liver Regeneration |
| Yastremsky F |
- |
Activated Protein C Resistance and Factor V Arg306Thr Mutation: A Case Report |
| Yastrubinetskaya OI |
- |
Home Treatment of Patients with Hemophilia Using Clotting Factor Concentrates VIII and IX ‘Ahemphil A’ and ‘Ahemphil B’ |
| Yasuda S |
- |
Determination of IgM Phosphatidylserine Dependent Antiprothrombin Antibodies Improves the Diagnostic Yield of Antiphospholipid Syndrome |
| Yasuda C |
- |
Prevention of Postoperative Pulmonary Embolism in the Japanese Academic Medical Center |
| Yasunori A |
- |
Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer |
| Yasunori S |
- |
Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors |
| Yatagai C |
- |
Nattokinase and Vitamin K2 Production Using Sake Cake, in Particular Distilled Cake, as the Fermented Material |
| Yates P |
- |
Queensland Health Pathology Service Statewide Coagulation Quality Control Database: the First Three Years Experience |
| Yatomi Y |
- |
Aspirin Resistance Detected with Aggregometry Can Not Be Explained by Failure to Suppress Cyclooxygenase Activity: Possible Involvement of Other Signaling Pathway(s) in Cardiovascular Events of Aspirin-treated Patients |
| Yavuz AS |
- |
Short-Course Use of Recombinant Factor VIIa in a Hemophilia Patient with Inhibitor Undergoing Cataract Surgeries |
| |
- |
von Willebrand Disease Type 2N (Normandy) in Three Siblings |
| Ye CC |
- |
Detection of Platelet Dense Granule Deficiency in Pediatric Patients by Quantitative Electron Microscopy |
| Ye P-Q |
- |
Immunomodulation of Transgene Responses Following Naked DNA Transfer of FVIII into Hemophilia A Mice |
| Ye W |
- |
Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China |
| Ye C |
- |
Alpha Granule formation in Megakaryocytes and Platelets Requires VPS33B, A Member of the Sec1/Munc18 (SM) Protein Family |
| Yeh IM |
- |
Genetic Frequencies of Single Nucleotide Polymorphisms in Predisposition to a Hypercoagulable State in Taiwan |
| Yélamos J |
- |
Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome |
| Yen MH |
- |
Inhibitory Effects of Andrographolide on LPS-Induced Tissue Factor Expression in Human Monocytic THP-1 Cells |
| Yeskaraev R |
- |
Evaluation of Pro-angiogenic and Pro-Coagulant Activity of Irradiated, Non Irradiated and Filtered Stored Blood Used in Transfusion Practice |
| Yeung AC |
- |
Reduction of Ex Vivo Thrombus Evolution with Anti-Platelet Therapy during Percutaneous Coronary Intervention: The REVEAL Study |
| Yevdokimova N |
- |
D-dimer-Induced Derangement of Endothelial Extracellular Matrix Partially Is Mediated by TSP-1-Dependent Activation of TGFbeta1 |
| Yi ZS |
- |
The Detection of the Platelet Activation by Flow Cytometry in the Patients with Pre-eclampsia |
| Yi Q |
- |
Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial |
| |
- |
Protein Z Gene Polymorphisms, Protein Z Concentration and Ischaemic Stroke |
| Yi KY |
- |
Cardioprotective Effect of KR-32568, a Novel Sodium/hydrogen Exchanger-1 Inhibitor, in a Rat Model of Ischemia and Reperfusion Heart Injury |
| |
- |
Antiplatelet Activity of KR-32560, a Novel Selective Sodium/hydrogen Exchanger-1 Inhibitor |
| Yim DJ |
- |
Thymidylate Synthase: A Possible Independent Risk Factor for Silent Brain Infarction |
| Yin ET |
- |
Heptest®-POC-Hi, a New Simple One-Step Point of Care (POC) Anti-Xa Clotting Assay for Monitoring Heparin Activity During Cardiac Surgery |
| Yip J |
- |
Interaction of Calmodulin with the Platelet ADP Receptor P2Y1 |
| Yiqun H |
- |
Novel Aberrant Splicings Caused by a Splice Site Mutation IVS1a+5g > a in F7 Gene |
| Yngen M |
- |
Food Intake Enhances Platelet Reactivity to Thromboxane in Type 2 Diabetic Patients |
| Yngen M |
- |
Postprandial Hyperglycaemia Induces Platelet Activation in Type 2 Diabetes Mellitus: Effects of Treatment with Repaglinide and Glibenclamide |
| |
- |
Effects of Improved Metabolic Control on Platelet Reactivity in Patients with Type 2 Diabetes Mellitus Following Coronary Angioplasty |
| Yoho J |
- |
Over Estimation of Aspirin Resistance: 1 Out of 143 Patients Exhibiting True Aspirin Resistance |
| |
- |
The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting |
| |
- |
High Dose Clopidogrel and Eptifibatide: The Optimum Strategy to Prevent Myocardial Necrosis in Elective Stenting? Results from the CLEAR PLATELET Study |
| |
- |
Clopidogrel Effect on Platelet Reactivity in Patients with Stent Thrombosis: Results of the CREST Study |
| Yoichi S |
- |
Fatal Hemorrhagic Disorder and Vascular Intimal Carcinomatosis in Annexin II Expressing Transitional Cell Carcinoma |
| Yokoi T |
- |
Age-Related Effects of Regular Physical Activity on Coagulation Factors in Men |
| Yokota E |
- |
A Calcium-dependent Anti-human Coagulation Factor IX Monoclonal Antibody That Recognizes Phospho-serine (158) of the Activation Peptide Region |
| Yokoyama K |
- |
Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver |
| Yonemitsu Y |
- |
Paracrine Loop between VEGF-C/Flt-4 and PDGF-BB/PDGFR-Beta Systems Contributes Therapeutic Angiogenesis Using FGF-2 Gene Transfer in Ischemic Hind Limbs |
| Yong T |
- |
An Audit on D-dimer Use in the Assessment of Patients with Suspected Acute Pulmonary Embolism |
| Yong S-L |
- |
Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B |
| Yongyut H |
- |
Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake |
| Yoo SJ |
- |
IgM Anti-beta2 Glycoprotein I Antibody as Potential Risk Factor of Thrombosis in Patients with Lupus Anticoagulants |
| Yoo HS |
- |
Inhibitory Effect of Luteolin on the PDGF-Induced Proliferation of Rat Aortic Vascular Smooth Muscle Cells |
| Yoo SE |
- |
Antiplatelet Activity of KR-32560, a Novel Selective Sodium/hydrogen Exchanger-1 Inhibitor |
| |
- |
Cardioprotective Effect of KR-32568, a Novel Sodium/hydrogen Exchanger-1 Inhibitor, in a Rat Model of Ischemia and Reperfusion Heart Injury |
| Yoshida M |
- |
Factor VII Arg277His Mutation Induced Discrepancy of Factor VII Activity Levels Using Tissue Factor from Different Sources |
| Yoshihashi K |
- |
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies |
| Yoshihiko M |
- |
Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors |
| Yoshikazu Y |
- |
Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors |
| Yoshioka A |
- |
Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| |
- |
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies |
| |
- |
Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| |
- |
Characterization of Recombinant Canine Factor VIII and Quantitative Determination of Factor VIII in Canine Plasma |
| |
- |
Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A |
| Yoshitake M |
- |
GPVI-Deficient Mice Lack Collagen Responses and are Protected Against Experimentally-Induced Pulmonary Thromboembolism |
| |
- |
Highly Potent Anti-human GPVI Monoclonal Antibodies Derived from GPVI Knockout Mouse Immunization |
| Young L |
- |
Post Treatment Residual Thrombus Is Associated with an Increased Risk of DVT Recurrence, Mortality and a Trend Towards Increased Vascular Death |
| Young NL |
- |
A Comparison of the Canadian Hemophilia Outcomes – Kids Life Assessment Tool (CHO-KLAT) and the HaemoQoL |
| Young G |
- |
The Use of Recombinant Factor VIIa (rFVIIa) for the Treatment and Prevention of Excessive Bleeding in Non-Hemophiliac Children |
| Young M |
- |
Inflammation and Venous Thromboembolism in Hospitalized Medical Patients |
| Young NL |
- |
The Canadian Hemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT): Results of the Reliability and Validation Study |
| Young M |
- |
The 80+ Hemorrhagic Cohort Study – Rates, Severity and Predictors of Major Hemorrhage in a Cohort of Anticoagulated Atrial Fibrillation Patients |
| Young G |
- |
Pilot Dose Finding and Pharmacokinetic Study of Bivalirudin in Infants with Thrombosis |
| Youssef S |
- |
Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis |
| |
- |
Elevation of Thrombotic Biomarkers Reveals the Prothrombotic State of Genetically Diabetic (db/db) and Obese (ob/ob) Mice |
| Yu YY |
- |
Genetic Frequencies of Single Nucleotide Polymorphisms in Predisposition to a Hypercoagulable State in Taiwan |
| Yu ZQ |
- |
The Association of Arterial Thrombosis and Polymorphisms of Platelet Glycoproteins and von Willebrand Factor in the Chinese Population |
| Yu ZC |
- |
Changes of Factor VII Coagulant Activity in Oral Warfarin Patients |
| Yu Z |
- |
A Monoclonal Antibody Against Platelet GPVI Impaires the Interaction Between Platelet and Collagen |
| Yu S |
- |
Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis |
| Yu I-S |
- |
Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model |
| Yu AYH |
- |
The Time Courses of Fibrin Formation, Prothrombin Activation and TAFI Activation in Normal and Factor VIII-Deficient Plasma |
| Yuan Y |
- |
Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury |
| Yuan W |
- |
Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation |
| Yuasa H |
- |
Prevention of Postoperative Pulmonary Embolism in the Japanese Academic Medical Center |
| |
- |
Mechanism of Lipopolysaccharide-induced Decrease of Plasma Protein S: Its Expression in Hepatocytes and Sinusoidal Endothelial Cells Is Mediated by NFkB Activation |
| Yüksel A |
- |
Factor V Leiden and Prothrombin G20210A Mutations in Children with Cerebral Palsy |
| Yumiko M |
- |
Biological Properties of a Specific Gaq/11 Inhibitor, YM-254890, on Platelet Functions and Thrombus Formation under High-shear Stress |
| Yumin S |
- |
Strong Lupus Anticoagulant (LA) Appears to Interfere with Activated Protein C Resistance Assay (APCR) |
| Yun YP |
- |
The Antiplatelet Activity of Hesperetin Is Mainly Mediated By Inhibition of PLCg2 Phosphorylation and Its Downstream Signal Transduction |
| |
- |
Antiplatelet Activity of KR-32560, a Novel Selective Sodium/hydrogen Exchanger-1 Inhibitor |
| Yun YP |
- |
Cardioprotective Effect of KR-32568, a Novel Sodium/hydrogen Exchanger-1 Inhibitor, in a Rat Model of Ischemia and Reperfusion Heart Injury |
| Yun YP |
- |
Inhibitory Effect of Luteolin on the PDGF-Induced Proliferation of Rat Aortic Vascular Smooth Muscle Cells |
| Yuping Y |
- |
Importance of Temporal Flow Gradients and Integrin aIIbb3 Mechanotransduction for Shear-Activation of Platelets |
| Yuzawa Y |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
